Clinical Trial

The Effect of Asymmetrical vs. Symmetrical High Flow Nasal Cannula on the Work of Breathing

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 18, 2025 (before its estimated September 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this study randomized single-center crossover study is to evaluate the impact of asymmetrical versus symmetrical nasal high flow (NHF) therapy on work of breathing (WOB). The main question it aims to answer are: 1\. Does the asymmetrical NHF interface improve the work of breathing compared to the symmetrical NHF interface? Researchers will compare the symmetrical NHF interface to the symmetrical NHF interface to see if the the asymmetrical interface has a greater impact on the work of breathing. Participants will : 1. receive NHF via both interfaces (FiO₂ 0.21, 50 L/min) for 15 minutes, in random order, with esophageal pressure monitoring and bioelectrical impedance analysis performed. 2. baseline characteristics will me monitored throughout the interventions 3. Esophageal pressure and minute ventilation will be monitored.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-03.
Trial Details
NCT Number NCT07066566
Lead Sponsor Larissa University Hospital
Conditions Respiratory Disease (Clinically Stable Individuals - Patients Recovered From Respiratory Disease)
Enrollment 30 participants
Start Date 2024-04-09
Primary Completion 2025-09-01 (estimated)
Study Completion 2025-09-01 (estimated)
Updated on ClinicalTrials.gov 2025-07-18